Chemical Compound

Vemurafenib

CAS Registry Number 918504-65-1

Back to search Request a Quote

Primary Record

Vemurafenib

In stock: 6,917 g
Purity: 99.4 %
CAS: 918504-65-1

Compound Identifiers & Properties

CAS: 918504-65-1
PubChem CID: 42611257
SMILES: CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F
Canonical SMILES: CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F

Names & Synonyms

Vemurafenib
Zelboraf
918504-65-1
vemurafenibum
PLX-4032
PLX4032
Zelboraf (TN)
PLX 4032
Vemurafenib [USAN]
1029872-54-5
RG7204
Vemurafenib (PLX4032)
207SMY3FQT
Vemurafenib (Standard)
Vemurafenib [USAN:INN]
3og7
C23H18ClF2N3O3S
cc-7
RG 7204
RefChem:57849
UNII-207SMY3FQT
Vemurafenib (PLX4032, RG7204)
N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide
VEMURAFENIB [MI]
Vemurafenib; PLX4032
Vemurafenib;PLX-4032
VEMURAFENIB [INN]
VEMURAFENIB [JAN]
MFCD18074504
D0Y9EW
PLX4032 (Vemurafenib)
PLX4032 - Vemurafenib
RO 5185426
VEMURAFENIB [VANDF]
RG-7204
VEMURAFENIB [MART.]
PLX4032 ,Vemurafenib ,
Vemurafenib (PLX4032)?
VEMURAFENIB [WHO-DD]
CHEBI:63637
HSDB 8143
Vemurafenib (BRAF inhibitor)
SCHEMBL298931
DTXSID50238710
Vemurafenib (JAN/USAN/INN)
GTPL5893
orb1298741
orb1305565
QCR-44
RO5185426
CHEMBL1229517
Ro 51-85426
SCHEMBL29355460
SCHEMBL29356185
CTK8C3113
DTXCID00161201
EX-A053
L01XE15
SYN1161
VEMURAFENIB [ORANGE BOOK]
GPXBXXGIAQBQNI-UHFFFAOYSA-N
NSC761431
GLXC-90076
GLXC-90433
HMS3265M03
HMS3265M04
HMS3265N03
HMS3265N04
HMS3654P09
HMS3748G15
HMS5079B05
RO-5185426
AOB87705
BCP25783
EX-A1335
RO-51-85426
ABP000429
ANW-69692
BDBM50396483
EBC-17135
HB4285
HY-12057R
MSK165863
NSC800964
RW4117
s1267
Vemurafenib (PLX4032,RG7204)
ZINC52509366
AKOS007930804
ACN-030372
AM81259
AN-1313
CCG-264883
CS-0216
CS-O-10915
DB08881
FV15248
ME-0096
NSC-761431
NSC-800964
PB11741
RL05788
SDCCGSBI-0647659.P002
TRA0082406
C23-H18-Cl-F2-N3-O3-S
KS-0000002Q
Vemurafenib, 99% - 100MG 100mg
NCGC00250399-01
NCGC00250399-05
NCGC00250399-08
R7204
Vemurafenib, RG7204, RO5185426
4CA-1032
AC-25010
AK-56796
BC626573
BP-44063
HY-12057
N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide
SC-54548
SY067868
AB0031775
AB1009703
TC-158437
A3004
FT-0660388
FT-0675792
FT-0689782
NS00008103
ST24048327
SW218095-2
Y0473
BRAF(V600E) Kinase Inhibitor RO5185426
J2.870.988I
N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide
PLX-4032(RG7204)/PLX4032
A10739
A25476
BRAF (V600E) kinase inhibitor RO5185426
D09996
Q-3409
R-7204
AB01273970-01
AB01273970_03
N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-PropanesulfonaMide
EN300-23265091
Q423111
SR-01000941568
carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide
N-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide
SR-01000941568-1
BRD-K56343971-001-02-3
BRD-K56343971-001-05-6
BRD-K56343971-001-10-6
BRD-K56343971-001-12-2
BRD-K56343971-001-14-8
N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-B]pyridine
PLX4032,Vemurafenib, RG7204, RO5185426, Zelboraf
N-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-
N-(3-((5-(4-Chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4- difluorophenyl)propane-1-sulfonamide
N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl]propane-1-sulfonamide
2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride
1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3- yl)carbonyl)-2,4-difluorophenyl)-
1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-
1-PROPANESULFONAMIDE, N-[3-[[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]CARBONYL]-2,4-DIFLUOROPHENYL]-
PLX4032, RG7204, RO5185426, 1029872-54-5
(1R)-1-(4-Hydroxy-3-{[(1R)-6-methoxy-1-(4-methoxybenzyl)-2-methyl -1,2,3,4-tetrahydro-7-isoquinolinyl]oxy}benzyl)-6-methoxy-2-methy l-1,2,3,4-tetrahydro-7-isoquinolinol
1-Propanesulfonamide, N-[3-[[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-; N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide; PLX 4032; Propane-1-sulfonic acid [3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]amide; RG 7204; RO 5185426; Ro 51-85426; Vemurafenib; Zelboraf
1-Propanesulfonamide,N-[3-[[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-
1415041-85-8
3-[3-[(Propylsulfonyl)amino]-2,6-difluorobenzoyl]-5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine
5-(4-Chlorophenyl)-3-[3-[(propylsulfonyl)amino]-2,6-difluorobenzoyl]-1H-pyrrolo[2,3-b]pyridine
N-(2,4-Difluoro-3-(5-(pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)phenyl)propane-2-sulfinamide
n-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-1-propanesulfonamide
N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide
N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)-propane-1-sulfonamide
N-(3-{(5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl}-2,4- difluorophenyl)propane-1-sulfonamide
N-[2,4-Difluoro-3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-ylcarbonyl]phenyl]-1-propanesulfonamide
propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide